Position history for Grantham, Mayo, Van Otterloo & Co. LLC's holdings in ABBOTT LABORATORIES
Grantham, Mayo, Van Otterloo & Co. LLC holds 8.9M shares of ABT (ABBOTT LABORATORIES), worth $914.9M as of 2026-Q1. The position was increased (+5.0% shares). ABT represents 2.3% of Grantham, Mayo, Van Otterloo & Co. LLC's portfolio.
Current Value
$914.9M
Current Shares
8.9M
Total Value Change
+$313M
Total Shares Change
+3.1M
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 8.9M |
+5.0% |
| $914.9M |
| 2.3% |
| $113.61 |
57 |
| 2025-Q4 | Increased | 8.5M | +3.7% | $1.1B | 2.7% | $125.15 | 57 |
| 2025-Q3 | Increased | 8.2M | +4.6% | $1.1B | 3.1% | $131.85 | 61 |
| 2025-Q2 | Decreased | 7.8M | -3.6% | $1.1B | 3.2% | $132.52 | 0 |
| 2025-Q1 | Increased | 8.1M | +2.7% | $1.1B | 3.4% | $128.41 | 60 |
| 2024-Q4 | Increased | 7.9M | +11.1% | $893.2M | 2.9% | $110.14 | 61 |
| 2024-Q3 | Increased | 7.1M | +22.8% | $810.6M | 2.5% | $109.27 | 66 |
| 2024-Q2 | Increased | 5.8M | +7.1% | $601.9M | 2.0% | $100.45 | 58 |